GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lincoln Pharmaceuticals Ltd (BOM:531633) » Definitions » Inventory-to-Revenue

Lincoln Pharmaceuticals (BOM:531633) Inventory-to-Revenue : 0.58 (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Lincoln Pharmaceuticals Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Lincoln Pharmaceuticals's Average Total Inventories for the quarter that ended in Dec. 2024 was ₹848 Mil. Lincoln Pharmaceuticals's Revenue for the three months ended in Dec. 2024 was ₹1,466 Mil. Lincoln Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.58.

Lincoln Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Dec. 2024 increased from Sep. 2024 (0.53) to Sep. 2024 (0.58)

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Lincoln Pharmaceuticals's Days Inventory for the three months ended in Dec. 2024 was 112.70.

Inventory Turnover measures how fast the company turns over its inventory within a year. Lincoln Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.81.


Lincoln Pharmaceuticals Inventory-to-Revenue Historical Data

The historical data trend for Lincoln Pharmaceuticals's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lincoln Pharmaceuticals Inventory-to-Revenue Chart

Lincoln Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Inventory-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.11 0.13 0.14 0.13

Lincoln Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 0.58 0.52 0.53 0.58

Competitive Comparison of Lincoln Pharmaceuticals's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Lincoln Pharmaceuticals's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lincoln Pharmaceuticals's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lincoln Pharmaceuticals's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Lincoln Pharmaceuticals's Inventory-to-Revenue falls into.


;
;

Lincoln Pharmaceuticals Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Lincoln Pharmaceuticals's Inventory-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Inventory-to-Revenue (A: Mar. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Mar. 2023 ) + Total Inventories (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )
=( (700.279 + 771.681) / 2 ) / 5712.178
=735.98 / 5712.178
=0.13

Lincoln Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue (Q: Dec. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Sep. 2024 ) + Total Inventories (Q: Dec. 2024 )) / count ) / Revenue (Q: Dec. 2024 )
=( (847.729 + 0) / 1 ) / 1465.517
=847.729 / 1465.517
=0.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lincoln Pharmaceuticals  (BOM:531633) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Lincoln Pharmaceuticals's Days Inventory for the three months ended in Dec. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2024 )/Cost of Goods Sold (Q: Dec. 2024 )*Days in Period
=847.729/686.356*365 / 4
=112.70

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Lincoln Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2024 ) / Average Total Inventories (Q: Dec. 2024 )
=686.356 / 847.729
=0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lincoln Pharmaceuticals Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lincoln Pharmaceuticals's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Lincoln Pharmaceuticals Business Description

Traded in Other Exchanges
Address
Science City Road, Lincoln House, Behind Satyam Complex, Sola, Ahmedabad, GJ, IND, 380060
Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin, analgesics, anesthetics, anti-pyretic, GIT products, vitamin-minerals, and iron preparations. Some of the key brands through which the company markets its products are; Rhino, Binafin, Kezolin, Hepalin, Progut, and Vomistat among others. Geographically, it carries out sales in India and outside India; generating key revenue from outside India.

Lincoln Pharmaceuticals Headlines

No Headlines